FETAL FIBRONECTIN ENZYME IMMUNOASSAY: payments to doctors
Payments that named FETAL FIBRONECTIN ENZYME IMMUNOASSAY as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $213K
- Providers
- 581
- Transactions
- 791
- Average per transaction
- $269
The per-transaction average — $269 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 581 providers the average total is $366, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Hologic Sales And Service, LLC | $108,570 | 51.0% |
| Gen-probe, Inc. | $66,227 | 31.1% |
| Hologic Inc | $28,911 | 13.6% |
| Hologic, LLC | $7,552 | 3.5% |
| Gen-probe Sales & Service, Inc. | $1,614 | 0.8% |